The Joint United Nations Programme on HIV/AIDS (UNAIDS) Technical Support
Mechanism (TSM) was established in 2018 and is mainly funded by the United States
Government through an agreement with the United States Agency for International
Development (USAID). The TSM assists countries in consolidating and focusing their
HIV responses to deliver effective programming, strengthening Global Fund to Fight
AIDS, Tuberculosis, and Malaria (Global Fund) grants, and supporting implementation
and sustainability. This Annual Report provides an overview of the achievements of the TSM for the reporting period 1 October 2022 to 30 September 2023.

As progress lags in achieving most of the health targets of United Nations Sustainable Development Goal 3 (SDG 3), efforts to end AIDS as a public health threat by 2030 stand out as a beacon of hope. Since 2010, annual new HIV infections and AIDS-related deaths have declined globally by 38% and 51%, respectively. Although the world as a whole is not currently on track to reach all the SDG targets, evidence clearly indicates that ending AIDS as a public health threat by 2030 is achievable and that clear pathways exist to reach this goal.

This framework and its accompanying toolkit are designed to help the Joint Programme support countries and communities in their efforts to identify HIV-related inequalities and their drivers and to address them according to the Joint Programme’s comparative advantages and capacity—and, in doing so, support the full realization of human rights.

The Compendium documents 41 promising practices that provide evidence of the core roles that faith communities have played in identifying undiagnosed children living with HIV, improving continuity of treatment, supporting adolescents to access psychosocial support, care and treatment, and enabling peer support groups to empower children and adolescents living with HIV. Also available: Feature story | Executive summary | Portuguese

The Global HIV Prevention Coalition focus countries are progressing unevenly towards the goal of reducing HIV infections to levels that would no longer constitute a public health threat. The biggest declines are occurring in eastern and southern Africa and, to a lesser degree, in western and central Africa. Expansion of access to effective ART, combined with an ongoing focus on primary prevention, are driving those achievements.

In 2024, five years later, the data show that people who inject drugs are still being left behind in the response. In 2022, the global median HIV prevalence among people who inject drugs was 5% across 50 reporting countries, seven times higher than among the rest of the adult population (aged 15–49 years). This figure hides significant geographical and population-based disparities. Among reporting countries, HIV prevalence ranged from 0% to 51%. Among the 16 countries with gender disaggregated data, the reported median HIV prevalence among men who inject drugs was 9%, while it was nearly double (15%) among women who inject drugs.

The Code of Conduct applies to any UNAIDS event or gathering, which shall include but is not limited to meetings, conferences and symposia, assemblies, receptions, scientific and technical events, expert meetings, workshops, exhibits, side events, and any other forum organized, hosted or sponsored in whole or part by UNAIDS. Such UNAIDS event or gathering, whether it is organized, hosted, or sponsored by UNAIDS, may take place in person or online, within/on or outside UNAIDS premises.